Medicare Enrolled
Dr. Thomas Del Guercio, M.D.
Pain Medicine · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Del Guercio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Del Guercio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Del Guercio
Dr. Thomas Del Guercio is a pain medicine specialist in Brooklyn, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Del Guercio performed 2,952 Medicare services across 1,227 unique beneficiaries.
Between the years covered by Open Payments, Dr. Del Guercio received a total of $18,168 from 28 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Del Guercio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 23% volume in NY
$18,168 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,952
Medicare services
Top 23% in NY for pain medicine
1,227
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~246 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
616 | $1 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
605 | $0 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $103 | $149 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $74 | $103 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
171 | $5 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
137 | $138 | $188 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
72 | $43 | $61 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
65 | $223 | $329 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $105 | $163 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $91 | $124 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
36 | $60 | $87 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
36 | $93 | $141 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
30 | $236 | $343 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
25 | $44 | $64 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
23 | $99 | $135 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
20 | $206 | $287 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $48 | $66 |
| Hip joint contrast injection for imaging A contrast dye is injected into the hip joint to enhance visibility during medical imaging procedures. |
17 | $208 | $279 |
| Radiologist review of hip joint image A radiologist examines and interprets an image of the hip joint to assess its condition. |
17 | $115 | $150 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
16 | $34 | $45 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
16 | $30 | $50 |
| Knee X-ray, 4 or more views An imaging test using X-rays to create multiple pictures of the knee joint from different angles. |
16 | $41 | $58 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
15 | $144 | $284 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
15 | $102 | $133 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
14 | $39 | $55 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $57 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,168
Total received (2019-2024)
Avg $3,634/year across 5 years
Top 4% in NY for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
275
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,051 (99.4%)
Scientific / Research
Research funding and grants
$117 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,418
2023
$2,382
2022
$4,252
2021
$1,025
2019
$90
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$5,729
BIOTRONIK NRO, Inc.
$1,281
Boston Scientific Corporation
$862
Nalu Medical, Inc.
$642
SPR Therapeutics, Inc
$578
Medtronic, Inc.
$448
Vertos Medical, Inc.
$187
Nevro Corp.
$145
Stryker Corporation
$135
Radius Health, Inc.
$125
Averitas Pharma Inc.
$90
Collegium Pharmaceutical, Inc.
$48
DePuy Synthes Sales Inc.
$39
PAINTEQ LLC
$29
Bioventus LLC
$25
Epimed International, Inc
$19
Saluda Medical Americas, Inc.
$19
IBSA Pharma Inc.
$17
Top 3 companies account for 75.6% of 2024 payments
All-time payments by company (2019-2024) ›
Abbott Laboratories
$6,250
BIOTRONIK NRO, Inc.
$1,422
SPR Therapeutics, Inc
$1,366
Nalu Medical, Inc.
$1,300
Spinal Simplicity, LLC
$1,275
Medtronic, Inc.
$1,198
Boston Scientific Corporation
$1,074
MML US, Inc.
$1,013
Nevro Corp.
$878
Relievant Medsystems, Inc.
$601
Saluda Medical Americas, Inc.
$510
Vertos Medical, Inc.
$380
Stryker Corporation
$135
Radius Health, Inc.
$125
NuVasive, Inc.
$92
Merz North America, Inc.
$90
Averitas Pharma Inc.
$90
Stimwave Technologies Incorporated
$89
Collegium Pharmaceutical, Inc.
$48
Zimmer Biomet Holdings, Inc.
$42
DePuy Synthes Sales Inc.
$39
Avanos Medical
$30
PAINTEQ LLC
$29
Bioventus LLC
$25
Epimed International, Inc
$19
IBSA Pharma Inc.
$17
Merit Medical Systems Inc
$15
Scilex Pharmaceuticals Inc.
$13
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
AXIUM · Affixus Humeral Nail · BIOTRONIK · Belbuca · Catheters and Needles · DUROLANE · DYNACORD · ETERNA · Evoke · Evoke SCS · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · Nalu Neurostimulation System · OCTRODE · ORTHOVISC · OSTEOCOOL RF ABLATION SYSTEM · Omnia · PAINTEQ · PROCLAIM · Prospera · QUTENZA · RELINE · ReActiv8 · SPRINT PNS System · STAR Tumor Ablation System · SYNCHROMEDII · Senza · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion Indirect Decompression System · TRIVISC SODIUM HYALURONATE · Tirosint · Tymlos · WaveWriter Alpha Prime 16 · XEOMIN · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for pain medicine in NY.
Geographic Context
Pain medicines within 10 mi
46
Per 100K population
1.7
County median income
$78,548
Nearest hospital
MAIMONIDES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Del Guercio is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NY), with low-engagement industry engagement in the top 4% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Del Guercio experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Del Guercio performed 616 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Del Guercio receive payments from pharmaceutical companies?
Yes. Dr. Del Guercio received a total of $18,168 from 28 companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Del Guercio's costs compare to other pain medicines in Brooklyn?
Dr. Del Guercio's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Del Guercio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Brooklyn
Browse pain medicines in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in NY
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in NY
Which NY pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK NRO, Inc. Payments to Doctors
See all physicians who received payments from BIOTRONIK NRO, Inc.
By company
SPR Therapeutics, Inc Payments to Doctors
See all physicians who received payments from SPR Therapeutics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology